在成年人中成功实现了deferasirox缓慢脱敏的案例
Buket Basa Akdogan1, Ilkay Koca Kalkan1, Gozde Koycu Buhari1
1University of Health Sciences Ataturk Chest Diseases and Chest Surgery Education and Research Hospital, and.
Allergologie select
|August 30, 2024
概括
一个修改后的缓慢脱敏方案成功地管理了黄斑皮疹,这是deferasirox (铁化疗法) 的常见副作用,在一个成年血病患者中. 这种方法为药物反应提供了潜在的管理策略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 皮肤病学 皮肤病学
背景情况:
- 斑点斑点性皮疹影响10%的患者在铁化治疗deferasirox.
- 没有确定的协议存在管理deferasirox诱导的皮疹在成年人.
- 延迟型过敏是这些反应的可疑原因之一.
研究的目的:
- 在成年人中呈现出deferasirox诱导的黄斑发疹病例.
- 在成年患者中描述缓慢脱敏方案的成功适应和应用.
- 为了评估修改过敏的疗效和安全性,以管理deferasirox过敏.
主要方法:
- 一名23岁的女性患有严重的沙拉西米亚,在1周的deferasirox治疗后出现了皮疹.
- 一个修改后的缓慢脱敏协议,从儿科协议中改编,在没有预先药物治疗的情况下启动.
- 剂量从总剂量的1/100,000开始,逐渐增加2至2.5倍,以达到治疗剂量.
主要成果:
- 患者耐受了修改后的缓慢脱敏方案.
- 一种轻微的局部反应 (脸红,红血) 发生在0.1毫克,但没有进展.
- 该协议允许患者继续必要的铁化疗法.
结论:
- 缓慢脱敏是一种可行的和成功的策略,用于管理口腔deferasirox诱导的成年患者的黄斑发疹.
- 这种修改后的协议为在患有过敏反应的患者中继续进行拯救生命的铁化疗提供了潜在的解决方案.
- 进一步的研究可能会探索优化脱敏感化协议以更广泛的应用.
相关概念视频
Dosage Regimen: Fixed Dose
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...


